FDA Withdraws Approval of EVSCO Pharmaceuticals' New Animal Drugs

Summary

The FDA is amending its animal drug regulations to remove approval of two new animal drug applications (NADAs) held by EVSCO Pharmaceuticals, an affiliate of IGI, Inc., and withdrawing approval of these NADAs as announced in a separate notice published in the Federal Register.